SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-000502
Filing Date
2024-01-29
Accepted
2024-01-29 17:14:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5680
  Complete submission text file 0001950047-24-000502.txt   7215
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Subject) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38662 | Film No.: 24574629
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SUTRO BIOPHARMA, INC. 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address
Vasquez Nicki (Reporting) CIK: 0001877585 (see all company filings)

Type: 144